Ofloxacin (systemic) vs CYP1A2 Substrates

Interacting Drugs
Ofloxacin (systemic)
vs
CYP1A2 Substrates
Security Level
Moderate, Consider therapy modification
Mechanism
CYP1A2 Substrates: CYP1A2 Inhibitors (Strong) may decrease the metabolism of CYP1A2 Substrates.
Management
Consider therapy modification

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ofloxacin (systemic) vs CYP1A2 Substrates